![RadOnc Tables on Twitter: "New nomograms to replace Sedlis criteria 🚀 A better way to determine risk for post-op cervix ✨Nomograms for both SCC & ACC ✨Sedlis criteria is for 30% chance RadOnc Tables on Twitter: "New nomograms to replace Sedlis criteria 🚀 A better way to determine risk for post-op cervix ✨Nomograms for both SCC & ACC ✨Sedlis criteria is for 30% chance](https://pbs.twimg.com/media/E8DSdS1WQAAygxf.png)
RadOnc Tables on Twitter: "New nomograms to replace Sedlis criteria 🚀 A better way to determine risk for post-op cervix ✨Nomograms for both SCC & ACC ✨Sedlis criteria is for 30% chance
![Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 1 (2019) Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 1 (2019)](https://jnccn.org/view/journals/jnccn/17/1/full-0064fig11.jpg)
Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 1 (2019)
Retrospective analysis of prognosis using the Gynecology Oncology Group score of stage IB‑IIA node negative uterine cervical c
Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update?
![Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria - Gynecologic Oncology Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria - Gynecologic Oncology](https://www.gynecologiconcology-online.net/cms/asset/30148c31-ed61-4e87-8e1f-57a89d8aac79/gr1.jpg)
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria - Gynecologic Oncology
![Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage “bulky” cervical cancer and survival impact of histological subtype - ScienceDirect Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage “bulky” cervical cancer and survival impact of histological subtype - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0929664622003965-figs1.jpg)
Long-term treatment outcomes/toxicities of definite chemoradiotherapy (intensity-modulated radiation therapy) for early-stage “bulky” cervical cancer and survival impact of histological subtype - ScienceDirect
![From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? - ScienceDirect From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S009082582101324X-ga1.jpg)
From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups? - ScienceDirect
![Table 1 from Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). | Semantic Scholar Table 1 from Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6ddc3cac14dade2a979d9f70b660e32f3ee79e66/11-Table1-1.png)
Table 1 from Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG). | Semantic Scholar
![Table 2 from Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer | Semantic Scholar Table 2 from Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/eb57ca3e914189d8efe867b5730c82d6bd3fbce6/3-Table2-1.png)
Table 2 from Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer | Semantic Scholar
![ESGO 2022: Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort ESGO 2022: Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort](https://larvolclin.s3.us-west-2.amazonaws.com/resize_1667212745278426095635fa5c9ed981.jpg)
ESGO 2022: Sentinel node biopsy diminishes de use of adjuvant therapy in women with early cervical cancer in the SUCCOR cohort
![Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis - ScienceDirect Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1028455921003107-gr1.jpg)
Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis - ScienceDirect
Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG)
![Table 1 from Cervical biopsy and excision procedure specimens lack sufficient predictive value for lymph-vascular space invasion seen at hysterectomy for cervical cancer. | Semantic Scholar Table 1 from Cervical biopsy and excision procedure specimens lack sufficient predictive value for lymph-vascular space invasion seen at hysterectomy for cervical cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/dc9f8ac41c7698076b4fe53f052f30969fb47263/2-Table1-1.png)